Home › NDC Lookup › RxCUI directory › RxCUI 307650

Abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet — RxCUI 307650

RxNorm drug concept · Semantic clinical drug
RxCUI 307650 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 0 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI307650
Official nameAbacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asabacavir 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet; abacavir sulfate 300 MG / lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet; abacavir (as abacavir sulfate) 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet
FDA products mapped1
Package NDCs mapped0
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Zidovudine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The injectable form of Retrovir is used when you can't take medicine by mouth — for example, during surgery, labor, or if you're too unwell to swallow. It's given directly into a v...
  • Why am I getting zidovudine as an injection instead of a pill?
  • Yes — this is one of the most important uses of Retrovir. In a well-designed clinical study, treating HIV-positive mothers with zidovudine during pregnancy and labor, and then trea...
  • Can zidovudine really lower the chances of passing HIV to my baby?
📖 Read our full Zidovudine Injection guide →

🕸️ Concept Web — How Abacavir 300 MG / lamivudine 150 MG / zidovudine... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet RxCUI 307650

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Abacavir 190521
    • Lamivudine 68244
    • Zidovudine 11413
    • Abacavir / lamivudine / zidovudine 284620
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Trizivir 284904
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Abacavir / lamivudine / zidovudine Oral Tablet 374813
    • Abacavir / lamivudine / zidovudine Oral Product 1163058
    • Abacavir / lamivudine / zidovudine Pill 1163059
    • Abacavir / lamivudine / zidovudine Oral Tablet [Trizivir] 368153
    • Trizivir Oral Product 1185593
    • Trizivir Pill 1185594
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Abacavir 300 MG 329485
    • Lamivudine 150 MG 316127
    • Zidovudine 300 MG 316916
    • Abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet [Trizivir] 285028
    • Abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG [Trizivir] 575077

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Abacavir 300 MG SCDC · 329485
  • Lamivudine 150 MG SCDC · 316127
  • Zidovudine 300 MG SCDC · 316916
  • Abacavir / lamivudine / zidovudine Oral Tablet SCDF · 374813
  • Abacavir / lamivudine / zidovudine Oral Product SCDG · 1163058
  • Abacavir / lamivudine / zidovudine Pill SCDG · 1163059

Brand-Name Concepts

  • Abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet [Trizivir] SBD · 285028
  • Abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG [Trizivir] SBDC · 575077
  • Abacavir / lamivudine / zidovudine Oral Tablet [Trizivir] SBDF · 368153
  • Trizivir Oral Product SBDG · 1185593
  • Trizivir Pill SBDG · 1185594
  • Trizivir BN · 284904

📦 FDA Products & Package NDCs

1 product · 0 package NDCs
No package NDCs are mapped to this concept in the current snapshot. Missing rows here mean the openFDA export did not annotate a listing with this RxCUI — never that no product exists.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.